RxDoctor Payments DataLook up a doctor →

Teddy Webb, MD

Family Medicine · Oklahoma City, OKNPI 1508890666

Payments from drug & device makers

$14,751in general payments, 2019–2025

Across 1,120 payments — averaging $13.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Pfizer$1K
  • GSK$999
  • AstraZeneca$980
  • Lilly USA, LLC$851
  • plus $8K from 50 others

What the payments were for

  • Food & beverage$14,57299%
  • Education$1791%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)153$1,549
Novo Nordisk131$1,318
Pfizer120$1,312
GSK85$999
AstraZeneca30$980
Lilly USA, LLC67$851
Boehringer Ingelheim63$820
Astellas Pharma US Inc41$743
Amarin Pharma, Inc.52$628
Amgen(2 entities)35$572
Abbott40$524
Bayer34$468
Merck41$439
Johnson & Johnson25$343
Takeda Pharmaceuticals U.S.A., Inc.20$314
Corium, LLC14$288
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC19$273
Biohaven Pharmaceuticals, Inc.6$180
Genentech USA, Inc.12$178
Shire North American Group Inc10$154
Antares Pharma, Inc.9$123
Idorsia Pharmaceuticals US Inc7$122
Sanofi-aventis U.S. LLC8$117
Adlon Therapeutics L.p.7$113
Novartis6$86
Sumitomo Pharma America, Inc.4$82
Axsome Therapeutics, Inc.5$79
Kowa Pharmaceuticals America, Inc.6$76
Ironwood Pharmaceuticals, Inc5$74
Esperion Therapeutics, Inc.5$71
Eisai Inc.5$69
Biohaven Pharmaceutical Holding Company Ltd.4$66
Upsher-smith Laboratories LLC3$59
Jazz Pharmaceuticals Inc.4$58
Ironshore Pharmaceuticals Inc.3$56
Exact Sciences4$55
Aytu Biopharma, Inc.4$49
Sanofi Pasteur Inc.3$48
Amneal Pharmaceuticals LLC3$47
Scilex Pharmaceuticals Inc.2$30
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$30
Halozyme Inc2$29
Dynavax Technologies Corporation3$29
Dexcom, Inc.2$26
Almatica Pharma LLC2$26
Xeris Pharmaceuticals, Inc.1$24
Medtronic1$23
Clarus Therapeutics Inc.2$23
Inspire Medical Systems, Inc.1$22
Dynasplint Systems Inc.1$20
Sunovion Pharmaceuticals Inc.1$20
Gilead1$14
Phathom Pharmaceuticals, Inc.3$14
Supernus Pharmaceuticals, Inc.1$13
IBSA Pharma Inc.1$13
Nalpropion Pharmaceuticals LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,751 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$206,358
Medicare patients
700
Services billed
3,525

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin113$128,649
OzempicSemaglutide82$116,310
EliquisApixaban119$107,404
JanuviaSitagliptin Phosphate40$46,107
TrulicityDulaglutide24$40,341
FarxigaDapagliflozin Propanediol26$38,740
MounjaroTirzepatide28$35,768
Trelegy ElliptaFluticasone/Umeclidin/Vilanter50$33,820
XareltoRivaroxaban20$20,253
Tresiba Flextouch U-200Insulin Degludec15$16,712
MyrbetriqMirabegron16$15,228
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$13,939
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$12,819
Atorvastatin Calcium686$10,503
RybelsusSemaglutide11$10,357

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$820$128,649113 claims
Novo NordiskOzempic, Rybelsus$1,318$126,66793 claims
PfizerEliquis$1,312$107,404119 claims
Lilly USA, LLCTrulicity, Mounjaro$851$76,10852 claims
MerckJanuvia, Janumet Xr$439$52,68952 claims
GSKTrelegy Ellipta, Breo Ellipta$999$40,54061 claims
AstraZenecaFarxiga$980$38,74026 claims
Johnson & JohnsonXarelto$343$20,25320 claims
Astellas Pharma US IncMyrbetriq$743$15,22816 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$47$8,806797 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$314$4,99211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,730 family medicine providers in Oklahoma.

Other family medicine in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →